International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 8, Issue 2 (March-April 2026) Submit your research before last 3 days of April to publish your research paper in the issue of March-April.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 8 Issue 2
March-April 2026

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Pharmacoeconomic Evaluation of Antidiabetic drugs in Government Vs Private Hospitals

Author(s) Dr. Kampa Nagalakshmi, SK.Karishma, D.Chandrika, K.Mincy
Country India
Abstract ABSTRACT
Pharmacoeconomic evaluation plays a vital role in optimizing healthcare resource utilization, particularly in the management of chronic diseases such as diabetes mellitus. This study aimed to compare the cost-effectiveness of antidiabetic drug therapy provided in government hospitals versus private hospitals and to assess the economic burden on patients. The primary objective of the study is to identify prescription pattern by using WHO core investigators. A comparative pharmacoeconomic evaluation was conducted using cost-minimization and cost-effectiveness approaches. Data were collected from patient records in selected government and private hospitals, including direct medical costs such as medication costs, laboratory investigations, consultation fees, and hospitalization charges.
The study highlights that government hospitals offer a more cost-effective approach for the management of diabetes mellitus, particularly for patients from low and middle socioeconomic backgrounds. Pharmacoeconomic evaluation of antidiabetic therapy can support policymakers and healthcare providers in decision-making to improve affordability, access, and rational use of medicines. Enhancing the availability of economic burden of diabetes and improve overall healthcare outcomes.
Keywords Pharmacoeconomic Evaluation, Antidiabetic dugs, Government and Private Hospital, Cost-effectiveness.
Field Medical / Pharmacy
Published In Volume 8, Issue 2, March-April 2026
Published On 2026-04-03
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 8 Isu 2Cover Page Vol 8 Isu 1Cover Page Vol 7 Isu 6

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9687-828-838 editor@ijfmr.com
Powered by Sky Research Publication and Journals